We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Novel MRI Method Could Predict Early Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

By MedImaging International staff writers
Posted on 18 Sep 2023
Print article
Image: A new MRI exam could predict chemotherapy’s effectiveness in breast cancer patients (Photo courtesy of 123RF)
Image: A new MRI exam could predict chemotherapy’s effectiveness in breast cancer patients (Photo courtesy of 123RF)

Neoadjuvant chemotherapy is often administered to shrink tumors before surgery in patients with breast cancer. However, due to the varying mutations within the same genes in breast tumors, almost 80% of patients experience either partial or no response to traditional chemotherapy. The conventional way to evaluate a patient's reaction to chemotherapy is by monitoring changes in the size of the tumor, a process that can take between four and six months and multiple treatment cycles. Researchers are now examining if a new type of MRI can assess the effectiveness of a chemotherapy regimen for women with breast cancer based on just one round of treatment.

Magnetic Resonance Fingerprinting (MRF) is an innovative MRI method that can examine multiple tissues in the body with a single, time-saving image or "fingerprint." This advanced technology has the potential for a wide range of clinical uses, including early disease identification and gauging how well a treatment is working. Researchers at Case Western Reserve University (Cleveland, OH, USA) are studying whether MRF can provide an early indication of how well neoadjuvant chemotherapy is working in breast cancer patients.

If MRF can deliver consistent insights into the effectiveness of neoadjuvant chemotherapy in breast cancer patients, it could help patients avoid treatments that are not required and enable physicians to explore other options more quickly. Early findings from their research suggest that MRF can accurately evaluate the effectiveness of therapy between seven and ten days after the first cycle of chemotherapy. This could greatly enhance patient care, offering the chance for more individualized treatment plans for many women.

“This study has great potential to bring real survival and quality-of-life benefits to our breast cancer patients,” said Yong Chen, an assistant professor of radiology at the Case Western Reserve School of Medicine. “The ultimate goal is to eliminate ineffective treatments in eligible subjects and instead tailor the treatment methods for optimum therapeutic outcomes for women with breast cancer.”

Related Links:
Case Western Reserve University 

Gold Supplier
Ultrasound System
Gold Supplier
Conductive Gel
Ferromagnetic Hand-Held Detector
FerrAlert Target Scanner
Silver Supplier
Bucky Protector
Bucky Protector

Print article



view channel
Image: Intelligent NR provides high-quality diagnostic images containing significantly less grainy noise (Photo courtesy of Canon)

AI-Driven DR System Produces Higher Quality Images While Limiting Radiation Doses in Pediatric Patients

Ionizing radiation is a fundamental element in producing diagnostic X-rays, yet it's widely acknowledged for its cancer risk potential. Digital projection radiography, a vital imaging modality, accounts... Read more


view channel
Image: The new ultrasound patch can measure how full the bladder is (Photo courtesy of MIT)

Ultrasound Patch Designed to Monitor Bladder and Kidney Health Could Enable Earlier Cancer Diagnosis

Bladder dysfunction and related health issues affect millions worldwide. Monitoring bladder volume is crucial for assessing kidney health. Traditionally, this requires a visit to a medical facility and... Read more

Nuclear Medicine

view channel
Image: A novel PET radiotracer facilitates early, noninvasive detection of IBD (Photo courtesy of Karmanos)

New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is an inflammatory condition of the gastrointestinal tract affecting roughly seven million individuals globally.... Read more

General/Advanced Imaging

view channel
Image: Artificial intelligence predicts therapy responses for ovarian cancer (Photo courtesy of 123RF)

AI Model Combines Blood Test and CT Scan Analysis to Predict Therapy Responses in Ovarian Cancer Patients

Ovarian cancer annually impacts thousands of women, with many diagnoses occurring at advanced stages due to subtle early symptoms. High-grade serous ovarian carcinoma, which accounts for 70-80% of ovarian... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Attendees can discover innovative products and technology in the RSNA 2023 Technical Exhibits (Photo courtesy of RSNA)

RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More

The 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA, Oak Brook, IL, USA) to be held in Chicago, Nov. 26 to 30 is all set to offer a vast array of medical... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.